Imperva Plans NYSE Listing
Data protection developer Imperva plans to hold its IPO on the New York Stock Exchange at a company value of $309-354 million in the second week of November. The underwriters, led by JPMorgan Chase Inc. and Deutsche Bank Securities LLC, along with RBC Capital Markets, Lazard Capital Markets, and Pacific Crest Partners, have an overallotment option to buy up to an additional 750,000 shares for $10.5-12 million. Two parties at interest, co-founders CTO Amichai Shulman and Mickey Boodaei also plan to sell 125,000 shares each in an offer to sell, for a total of $1.8-2 million.
31 October 2011•3 mins read
